Chimeric Rabies Virus Glycoprotein Fragment (RVG-9R) – 1 mg

Overview

Chimeric Rabies Virus Glycoprotein Fragment (RVG-9R) is a powerful peptide designed specifically for gene transduction in neuronal cells. Derived from the rabies virus glycoprotein, this peptide offers a novel approach to delivering siRNA across the blood-brain barrier. By incorporating nonamer arginine residues at the carboxy terminus, this unique composition enhances the ability of RVG-9R to bind and effectively transport siRNA into targeted cells. The result is efficient gene silencing, making it an invaluable tool for neuroscience research and therapeutic applications.

Key Features

• Designed for efficient siRNA delivery
• Facilitates transduction in neuronal cells
• Incorporates nonamer arginine residues for enhanced binding
• Ideal for research in neurological disorders
• Available in a convenient 1 mg format

Specifications

FAQ

What is RVG-9R used for?

RVG-9R is primarily utilized to deliver siRNA into neuronal cells, allowing for targeted gene silencing in research related to neurological conditions.

How does RVG-9R facilitate siRNA delivery?

This peptide binds siRNA and helps transduce it into neuronal cells by crossing the blood-brain barrier, leveraging the natural infection mechanism of neurotropic viruses.

Where can I learn more about related products?

You might find interest in our PKG Substrate or Autocamtide-2both essential for various biochemical applications.

For additional options, browse our peptides catalog for more innovative solutions to enhance your research results.

Related Products

• CREBtide [KRREILSRRPSYR], 5-FAM labeled